Aphria Inc (NYSE:APHA) – Stock analysts at Cantor Fitzgerald issued their FY2020 EPS estimates for Aphria in a research note issued to investors on Wednesday, January 15th. Cantor Fitzgerald analyst P. Zuanic anticipates that the company will post earnings of ($0.04) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $10.40 price target on the stock.
APHA has been the subject of a number of other research reports. Zacks Investment Research downgraded Aphria from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 6th. Pi Financial set a $9.00 price target on Aphria and gave the company a “buy” rating in a report on Tuesday, October 15th. CIBC raised Aphria from an “underperform” rating to a “neutral” rating and set a $7.00 price target for the company in a report on Tuesday, January 14th. Jefferies Financial Group reaffirmed a “buy” rating and set a $10.30 price target on shares of Aphria in a report on Monday. Finally, Bank of America started coverage on Aphria in a report on Monday, January 13th. They set a “neutral” rating for the company. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Aphria has a consensus rating of “Buy” and a consensus target price of $12.34.
NYSE APHA opened at $5.27 on Monday. Aphria has a 52-week low of $3.76 and a 52-week high of $10.95. The business has a 50 day simple moving average of $5.00 and a 200 day simple moving average of $5.57. The stock has a market cap of $1.33 billion, a price-to-earnings ratio of -21.08 and a beta of 2.78.
Several hedge funds have recently made changes to their positions in the company. Bank of America Corp DE increased its holdings in Aphria by 410.2% in the second quarter. Bank of America Corp DE now owns 507,034 shares of the company’s stock worth $3,554,000 after purchasing an additional 407,658 shares in the last quarter. Renaissance Technologies LLC bought a new stake in Aphria in the second quarter worth approximately $1,700,000. K2 Principal Fund L.P. increased its holdings in Aphria by 116.8% in the third quarter. K2 Principal Fund L.P. now owns 25,200 shares of the company’s stock worth $173,000 after purchasing an additional 175,200 shares in the last quarter. Vanguard Group Inc. increased its holdings in Aphria by 2.6% in the second quarter. Vanguard Group Inc. now owns 5,402,302 shares of the company’s stock worth $37,870,000 after purchasing an additional 135,714 shares in the last quarter. Finally, Cubist Systematic Strategies LLC bought a new stake in Aphria in the second quarter worth approximately $796,000. 9.62% of the stock is currently owned by hedge funds and other institutional investors.
About Aphria
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.